BIOMIMETIC THERAPEUTICS INC has a total of 102 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and China. Its main competitors in its focus markets pharmaceuticals, medical technology and environmental technology are LYNCH SAMUEL E, BIOMIMETIC THERAPEUTICS LLC and Z MEDICA CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 15 | |
#2 | Canada | 13 | |
#3 | China | 13 | |
#4 | United States | 9 | |
#5 | Japan | 8 | |
#6 | Republic of Korea | 8 | |
#7 | Brazil | 7 | |
#8 | EPO (European Patent Office) | 7 | |
#9 | Australia | 6 | |
#10 | Mexico | 4 | |
#11 | New Zealand | 4 | |
#12 | Israel | 3 | |
#13 | South Africa | 3 | |
#14 | Hong Kong | 1 | |
#15 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Environmental technology | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Object sterilising | |
#3 | Medical preparations | |
#4 | Implantable devices | |
#5 | Climate change adaptation technologies | |
#6 | Dentistry | |
#7 | Peptides | |
#8 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Lynch Samuel E | 51 |
#2 | Hart Charles E | 27 |
#3 | Kestler Hans K | 22 |
#4 | Wisner-Lynch Leslie A | 18 |
#5 | Liu Yanchun | 17 |
#6 | Young Conan S | 12 |
#7 | Snel Leo B | 11 |
#8 | Lynch Samuel | 9 |
#9 | Samuel E Lynch | 9 |
#10 | Nickols Joshua | 8 |
Publication | Filing date | Title |
---|---|---|
AU2013203300A1 | Compositions and methods for treating bone | |
WO2013062995A1 | Compositions and methods for treating deep partial and full thickness wounds and injuries | |
US2013108670A1 | Compositions and methods for treating full thickness burn injuries | |
CN107080834A | Platelet-derived growth factor compositions and method for treating tendon disease | |
BRPI1010246A2 | platelet-derived growth factor compositions and methods for treating osteochondral defects | |
KR20110135949A | Platelet-derived growth factor compositions and methods for the treatment of osteochondral defects | |
CN102316890A | Bone graft and the method for selection and use with proteinase activity of reduction | |
CN102014977A | Compositions and methods for distraction osteogenesis | |
CN101820895A | The compositions and the method that are used for the treatment of spinal column | |
US2007207185A1 | Compositions and methods for treating bone | |
BRPI0618794A2 | use of a biocompatible matrix, kit and composition for bone augmentation, especially for maxillofacial bone augmentation | |
US2006084602A1 | Platelet-derived growth factor compositions and methods of use thereof |